Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
3,205.73
2,942.90
2,487.98
2,105.18
1,318.25
1,252.09
1,180.94
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
3,205.73
2,942.90
2,487.98
2,105.18
1,318.25
1,252.09
1,180.94
Raw Material Cost
2,016.55
1,879.17
1,601.45
1,356.42
872.83
808.06
745.99
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
106.69
104.14
70.49
41.83
25.40
25.10
11.53
Selling and Distribution Expenses
642.97
590.51
471.87
410.10
319.68
289.70
286.16
Other Expenses
-10.67
-10.41
-7.05
-4.18
-2.54
-2.51
-1.15
Total Expenditure (Excl Depreciation)
2,659.51
2,469.68
2,073.32
1,766.52
1,192.51
1,097.76
1,032.15
Operating Profit (PBDIT) excl Other Income
546.1999999999999
473.2
414.7
338.7
125.7
154.3
148.8
Other Income
25.07
31.69
29.96
26.49
53.56
13.06
12.47
Operating Profit (PBDIT)
707.61
631.93
536.71
479.86
273.80
260.12
232.67
Interest
106.69
104.14
70.49
41.83
25.40
25.10
11.53
Exceptional Items
0.00
0.00
0.00
0.00
16.39
13.39
0.00
Gross Profit (PBDT)
1,189.19
1,063.73
886.53
748.76
445.43
444.03
434.95
Depreciation
140.49
125.62
114.26
115.11
95.09
92.67
74.04
Profit Before Tax
460.43
402.17
351.95
322.91
169.70
155.74
147.10
Tax
18.22
14.89
33.69
16.93
13.44
4.71
3.54
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
471.20
360.12
274.46
258.60
131.99
146.92
141.76
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
471.20
360.12
274.46
258.60
131.99
146.92
141.76
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
13.97
25.30
20.98
16.31
2.98
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
485.18
385.42
295.44
274.91
134.97
146.92
141.76
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
3,468.56
3,203.39
1,989.85
1,866.79
1,794.58
1,522.13
1,601.21
Earnings per share (EPS)
4.83
3.7
3.05
2.87
1.53
1.69
1.58
Diluted Earnings per share
4.83
3.7
3.05
2.87
1.53
1.69
1.58
Operating Profit Margin (Excl OI)
16.91%
16.13%
15.78%
16.07%
9.49%
12.33%
12.38%
Gross Profit Margin
18.75%
17.93%
18.74%
20.81%
20.09%
19.84%
18.73%
PAT Margin
14.7%
12.24%
11.03%
12.28%
10.01%
11.73%
12.0%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 8.93% vs 18.28% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 25.90% vs 30.47% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 13.71% vs 18.45% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is 2.50% vs 47.66% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of Dallah Healthcare Co. With
Figures in Million
Consolidate Annual Results
Change(SAR)
Change(%)
Net Sales
3,205.73
0
3,205.73
Other Operating Income
0.00
0.00
0.00
Total Operating income
3,205.73
0
3,205.73
Raw Material Cost
2,016.55
0
2,016.55
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
106.69
0
106.69
Selling and Distribution Expenses
642.97
0
642.97
Other Expenses
-10.67
0.00
-10.67
Total Expenditure (Excl Depreciation)
2,659.51
0
2,659.51
Operating Profit (PBDIT) excl Other Income
546.22
0.00
546.22
Other Income
25.07
0
25.07
Operating Profit (PBDIT)
707.61
0
707.61
Interest
106.69
0
106.69
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
1,189.19
0
1,189.19
Depreciation
140.49
0
140.49
Profit Before Tax
460.43
0
460.43
Tax
18.22
0
18.22
Provisions and contingencies
0
0
0.00
Profit After Tax
471.20
0
471.20
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
471.20
0
471.20
Share in Profit of Associates
0
0
0.00
Minority Interest
13.97
0
13.97
Other related items
0.00
0.00
0.00
Consolidated Net Profit
485.18
0
485.18
Equity Capital
0
0
0.00
Face Value
10.00
0
0.00
Reserves
3,468.56
0
3,468.56
Earnings per share (EPS)
4.83
0
4.83
Diluted Earnings per share
4.83
0
4.83
Operating Profit Margin (Excl OI)
16.91%
0%
0.00
16.91%
Gross Profit Margin
18.75%
0%
0.00
18.75%
PAT Margin
14.70%
0%
0.00
14.70%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 320.57 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 8.93% vs 18.28% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 48.52 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 25.90% vs 30.47% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 68.25 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 13.71% vs 18.45% in Dec 2023
Annual - Interest
Interest 10.67 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 2.50% vs 47.66% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 16.91%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023






